Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Dezember 2014 18:38 ET | Quelle: Codexis

Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme Therapeutic Candidate for the Potential Treatment of Phenylketonuria (PKU) via Oral Administration

REDWOOD CITY, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has...
25. November 2014 08:00 ET | Quelle: Codexis

Codexis to Present at the LD Micro Main Event VII Conference on December 4

REDWOOD CITY, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
04. November 2014 16:03 ET | Quelle: Codexis

Codexis Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2014

REDWOOD CITY, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial...
03. November 2014 16:01 ET | Quelle: Codexis

Codexis Appoints Pam P. Cheng, Merck Global Executive, to Board of Directors

REDWOOD CITY, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the...
21. Oktober 2014 08:00 ET | Quelle: Codexis

Codexis to Report Third Quarter 2014 Financial Results on November 4

REDWOOD CITY, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
22. September 2014 08:00 ET | Quelle: Codexis

Codexis Appoints Biotechnology Industry Veteran, Kathleen Glaub, to Board of Directors

REDWOOD CITY, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the...
06. August 2014 16:01 ET | Quelle: Codexis

Codexis Reports Financial Results for the Second Quarter of 2014

REDWOOD CITY, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its...
31. Juli 2014 16:36 ET | Quelle: Codexis

Codexis to Announce Second Quarter 2014 Financial Results on August 6, 2014

REDWOOD CITY, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will...
28. Juli 2014 16:01 ET | Quelle: Codexis

Gordon Sangster to Join Codexis as Senior Vice President & Chief Financial Officer

REDWOOD CITY, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that...
14. Juli 2014 16:01 ET | Quelle: Codexis

Codexis Announces Technology Collaboration and License Agreement With GSK

Codexis to Receive Up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities Codexis to Host a Conference Call on July 15, 2014 at 8:30 a.m. ET / 5:30 a.m....

Nächste Seite